Korean J Parasitol.  2019 Feb;57(1):39-41. 10.3347/kjp.2019.57.1.39.

Quantification of Immunoglobulin G against Trypanosoma cruzi in Individuals with Chronic Chagas Disease Treated with Nifurtimox and Evaluated in Prolonged Follow-Up

• Muñoz G
• Vergara C
• Martínez
• Apt W
• Zulantay I

• KMID: 2441605
• DOI: http://doi.org/10.3347/kjp.2019.57.1.39

Abstract

In the indeterminate chronic period of Chagas disease (ChD) the treatment has not been conclusive, because the serological negativization requires many years. This study aims to evaluate the efficacy of nifurtimox (NF) in the treatment of chronic ChD in prolonged follow-up by serological techniques of indirect immunofluorescence assay (IFA) and enzyme-linked immunosorbent assay (ELISA) IgG comparing 2 groups of patients, treated and non treated. Mann-Whitney test was performed for ELISA and IFA, with significant difference between the groups (P < 0.05). IgG levels were lower in individuals treated compared with untreated patients, indicating chemotherapeutic efficacy in prolonged follow-up.

Keyword

IFA; ELISA; chronic Chagas disease; IgG; nifurtimox; follow-up

MeSH Terms

Chagas Disease*
Enzyme-Linked Immunosorbent Assay
Fluorescent Antibody Technique, Indirect
Follow-Up Studies*
Humans
Immunoglobulin G*
Immunoglobulins*
Nifurtimox*
Trypanosoma cruzi*
Trypanosoma*
Immunoglobulin G
Immunoglobulins
Nifurtimox